This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aspiair Gmbh. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Sebastian Canisius
Introduction
Sebastian Canisius is a notable inventor based in Ebsdorfergrund, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of influenza. His innovative approach has led to the development of a unique pharmaceutical composition aimed at alleviating the symptoms associated with severe influenza virus infections.
Latest Patents
Sebastian Canisius holds a patent for the treatment of moderate to severe influenza. The invention provides a compound, namely acetylsalicylic acid (ASA) or a pharmaceutically acceptable salt thereof, for use in treating patients suffering from severe influenza virus infections. This treatment addresses various symptoms, including nasal congestion, sore throat, cough, fever, fatigue, headache, and myalgias. The administration of this composition is designed to be delivered by inhalation, offering a novel method for patient care.
Career Highlights
Canisius is associated with Aspiair GmbH, where he continues to work on innovative solutions in the pharmaceutical field. His dedication to research and development has positioned him as a key figure in the fight against influenza and similar viral infections.
Collaborations
Sebastian Canisius has collaborated with notable colleagues, including Gerhard Scheuch and Karlheinz Nocker. Their combined expertise has contributed to the advancement of medical treatments and innovations.
Conclusion
Sebastian Canisius exemplifies the spirit of innovation in the medical field through his patent for treating influenza. His work at Aspiair GmbH and collaborations with esteemed colleagues highlight his commitment to improving patient outcomes.